Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,562,999
  • Shares Outstanding, K 45,436
  • Annual Sales, $ 1,185 M
  • Annual Income, $ 2,050 K
  • EBIT $ 5 M
  • EBITDA $ 94 M
  • 60-Month Beta 0.79
  • Price/Sales 1.32
  • Price/Cash Flow 12.44
  • Price/Book 1.25

Options Overview Details

View History
  • Implied Volatility 64.21% (+8.16%)
  • Historical Volatility 68.40%
  • IV Percentile 71%
  • IV Rank 51.90%
  • IV High 89.58% on 04/08/25
  • IV Low 36.84% on 09/02/25
  • Expected Move (DTE 4) 2.58 (7.51%)
  • Put/Call Vol Ratio 14.50
  • Today's Volume 31
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 987
  • Open Int (30-Day) 1,085
  • Expected Range 31.82 to 36.98

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.13
  • Number of Estimates 3
  • High Estimate 0.16
  • Low Estimate 0.10
  • Prior Year 0.08
  • Growth Rate Est. (year over year) +62.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
33.87 +1.56%
on 03/13/26
42.60 -19.25%
on 02/26/26
-2.10 (-5.75%)
since 02/13/26
3-Month
33.87 +1.56%
on 03/13/26
55.00 -37.45%
on 01/13/26
-9.46 (-21.57%)
since 12/12/25
52-Week
22.66 +51.81%
on 05/06/25
55.00 -37.45%
on 01/13/26
+2.12 (+6.57%)
since 03/13/25

Most Recent Stories

More News
3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

OMCL : 35.27 (+2.53%)
3 Cash-Producing Stocks We Find Risky

3 Cash-Producing Stocks We Find Risky

MGM : 36.71 (+0.08%)
HOLX : 75.17 (+0.07%)
OMCL : 35.27 (+2.53%)
Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

GH : 88.25 (+3.23%)
OMCL : 35.27 (+2.53%)
PACB : 1.3800 (+3.76%)
ALGN : 165.41 (+0.72%)
QDEL : 17.57 (+2.75%)
The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

OMCL : 35.27 (+2.53%)
OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

OMCL : 35.27 (+2.53%)
Why Omnicell (OMCL) Shares Are Plunging Today

Why Omnicell (OMCL) Shares Are Plunging Today

OMCL : 35.27 (+2.53%)
Omnicell: Q4 Earnings Snapshot

Omnicell: Q4 Earnings Snapshot

OMCL : 35.27 (+2.53%)
Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

Omnicell’s (NASDAQ:OMCL) Q4 CY2025 Earnings Results: Revenue In Line With Expectations

OMCL : 35.27 (+2.53%)
Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

Omnicell delivers solid fourth quarter 2025 financial results A nnounces major step toward autonomous medication management with the launch of its next generation...

OMCL : 35.27 (+2.53%)
Omnicell Earnings: What To Look For From OMCL

Omnicell Earnings: What To Look For From OMCL

OMCL : 35.27 (+2.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed below 30%. The market has entered oversold territory.

See More Share

Business Summary

Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution,...

See More

Key Turning Points

3rd Resistance Point 37.14
2nd Resistance Point 36.38
1st Resistance Point 35.39
Last Price 35.27
1st Support Level 33.64
2nd Support Level 32.88
3rd Support Level 31.89

See More

52-Week High 55.00
Fibonacci 61.8% 42.65
Fibonacci 50% 38.83
Last Price 35.27
Fibonacci 38.2% 35.01
52-Week Low 22.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar